Frontiers in Alzheimer's Disease Research
Nova Publishers, 2006 - 353 Seiten
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control memory, thought and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory loss and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk for developing it, improving the accuracy of diagnosis and ability to identify who is at risk, developing, discovering and testing new treatments for behavioural problems in patients with AD. This book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.
Was andere dazu sagen - Rezension schreiben
Es wurden keine Rezensionen gefunden.
Synapse and Neuron Loss in Transgenic Mouse Models of Alzheimers Disease
Neuropsychological Manifestations in Preclinical Alzheimers Disease
Altered Brain Activation During Cognitive Process in Alzheimers Disease
Premature Centromere Division PCD of the X Chromosome as a BioMarker of the Brain Cells reEntry Into the Cell Division Cycle in Alzheimers Dise...
The Aging Brain The Risk Factor for Sporadic Alzheimers Disease SAD Cellular and Molecular Aspects
Remembering Emotional Information Effects of Aging and Alzheimers Disease
ApoE Anxiety and Alzheimers Disease
Insulin Resistance Depressive Disorders and Alzheimers Disease
Searching for Genetic Risk Factors in AD A NeverEnding Story
APOE and Cognitive Function in Nondemented Old Age A Genetic Basis for Brain or Cognitive Reserve?
action activity aggregates allele alterations Alzheimer disease Alzheimer's disease amyloid analysis anxiety APOE apolipoprotein apoptosis Aẞ assessed associated binding Biol blood brain cause cell death cerebral changes chromosome clinical cognitive impairment compared correlation cortex cytotoxic decline deficits dementia demonstrated depression disorders early effects emotional et al evidence expression extracellular factors familial findings formation function further gene genetic glucose hippocampal human important increased indicating induced influence inhibition insulin insulin receptor involved levels major measures mechanisms memory metabolism mice mild mutant neuritic Neurology neuron loss neuronal neuronal cell neuroprotective Neurosci normal observed oxidative pathway patients peptide performance plaques polymorphism population possible preclinical precursor protein present processes Psychiatry receptor reduced regions regulation reported response risk role showed signal significant sporadic stress studies subjects suggested transgenic mice transport treatment
Seite 138 - Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Seite 27 - Lewis, J., Dickson, DW, Lin, WL, Chisholm, L., Corral, A., Jones, G., Yen, S. H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M., and McGowan, E.
Seite 34 - Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Seite 118 - Games, D; Adams, D; Alessandrini, R; Barbour, R; Berthelette, P; Blackwell, C; Carr, T; Clemens, J; Donaldson, T; Gillespie, F...
Seite 38 - Morgan, D., Diamond, DM, Gottschall, PE, Ugen, KE, Dickey, C., Hardy, J., Duff, K., Jantzen. P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C.. Gordon, M...
Seite 93 - Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, MP, Appelmans, S., Oh, H., Van Damme, P., Rutten, B., Man, WY, De Mol, M., Wyns, S., Manka, D., Vermeulen, K., Van Den Bosch, L., Mertens, N., Schmitz, C., Robberecht, W., Conway, EM, Collen, D., Moons, L., and Carmeliet, P.
Seite 30 - K. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.
Seite 50 - Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86: 1343- 1346.